Methods for Nucleic Acid Cleavage
US-2024417778-A1 · Dec 19, 2024 · US
US9758812B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9758812-B2 |
| Application number | US-201214238801-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 13, 2012 |
| Priority date | Aug 17, 2011 |
| Publication date | Sep 12, 2017 |
| Grant date | Sep 12, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention is in the fields of molecular biology. The present invention is directed to novel compositions, methods and kits useful for the generation of nucleic acids from an RNA template and further nucleic acid replication. Specifically, the invention is directed to the generation and amplification of nucleic acids by reverse transcriptase-polymerase chain reaction.
Opening claim text (preview).
The invention claimed is: 1. A composition suitable for the generation of nucleic acids from reverse transcription of an RNA template followed by polymerase chain reaction amplification, said composition comprising an anionic polymer selected from the group consisting of sodium alginate, sodium carboxymethylcellulose, polyphloretin phosphate, poly-L-glutamate, polyacrylic acid, poly(propylacrylic acid) and poly(methyl-vinyl-ether-maelic anhydride), one or more oligonucleotide primers that facilitate reverse transcription of a nucleic acid molecule complementary to at least a portion of the RNA template and replication of the nucleic acid molecule by polymerase chain reaction amplification, one or more nucleotides or derivatives thereof, and two or more different polymerases, at least one of which has reverse transcriptase activity and at least one of which has nucleic acid polymerase activity. 2. The composition of claim 1 further comprising one or more selected from the group consisting of a buffering agent, a salt, DMSO, glycerol, formamide, betaine, tetramethylammonium chloride, PEG, polyoxyethylene (20) sorbitan monolaurate, NP 40, extoine, polyoles, E. coli SSB protein, Phage T4 gene 32 protein, and BSA. 3. The composition of claim 1 , wherein the anionic polymer comprises a net charge of at least −1 at a pH used in RT-PCR and comprises an amount of counterions sufficient for the anionic polymer to maintain electric neutrality. 4. A kit for performing coupled RT-PCR, said kit comprising at least one reverse transcriptase, at least one DNA polymerase, one or more oligonucleotide primers that facilitate reverse transcription of a nucleic acid molecule complementary to at least a portion of an RNA template and replication of the nucleic acid molecule by polymerase chain reaction amplification, and at least one anionic polymer that is not a nucleic acid selected from the group consisting of sodium alginate, sodium carboxymethylcellulose, polyphloretin phosphate, poly-L-glutamate, polyacrylic acid, poly(propylacrylic acid) and poly(methyl-vinyl-ether-maelic anhydride). 5. The kit according to claim 4 , further comprising a mixture of two or more of dATP, dCTP, dGTP, and dTTP, and/or one or more additives useful in RT-PCR and/or a buffering agent.
RNA dependent DNA polymerase,(i.e. reverse transcriptase) · CPC title
Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title
Polymerase chain reaction [PCR] · CPC title
Specific component of sample, medium or buffer · CPC title
cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.